Additional chemotherapy improves survival in stage II–III pulmonary sarcomatoid carcinoma patients undergoing surgery: a propensity scoring matching analysis

BACKGROUND: The role of additional chemotherapy in pulmonary sarcomatoid carcinoma (PSC) is controversial. This study aimed to investigate the function of chemotherapy in PSC patients with surgical resection. METHODS: PSC patient information between 2004 to 2016 was extracted from the Surveillance,...

Descripción completa

Detalles Bibliográficos
Autores principales: Cen, Yanhong, Yang, Chunxu, Ren, Jiangbo, Gong, Yan, Xie, Conghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859755/
https://www.ncbi.nlm.nih.gov/pubmed/33553317
http://dx.doi.org/10.21037/atm-20-3226

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859755/
https://www.ncbi.nlm.nih.gov/pubmed/33553317
http://dx.doi.org/10.21037/atm-20-3226

Ejemplares similares